|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| C12N 9/50 | (2006.01) | ||
| C12Q 1/37 | (2006.01) | ||
| G01N 33/50 | (2006.01) | ||
| G01N 33/53 | (2006.01) | ||
| G01N 33/573 | (2006.01) |
| (11) | Number of the document | 3281953 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17192861.7 |
| Date of filing the European patent application | 2010-03-12 | |
| (97) | Date of publication of the European application | 2018-02-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 160217 P | 2009-03-13 | US |
| (72) |
Wang, Joanne, US
Zhu, Hong, US
Hodges, D. Diane, US
Fernandez-Salas, Ester, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS |
| IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS |